ELMIRON® LAWSUIT

Since 1996, millions of individuals have taken Elmiron® to treat interstitial cystitis. Long-term use, however, has led to maculopathy in several consumers. Maculopathy starts with blurred vision, dark spots, and trouble focusing on up-close things in the field of vision. As it progresses, it can lead to total blindness. Millions of people are still taking this drug, while Janssen Pharmaceuticals faces lawsuits for failing to warn users of the potential risks.

Lawsuits are being filed against Janssen Pharmaceuticals alleging that the company failed to warn users about the risk of vision loss and other serious vision problems now associated with Elmiron®. As the connection between vision damage and Elmiron® was only made in April of 2020, no verdicts have been made in the cases filed against the company yet. If you suffered vision loss after taking Elmiron®, the time to take action with a lawsuit is now. Get in touch with Wolf of Justice™ today to get started.

Individuals who have regularly taken Elmiron® could be affected by its connection to maculopathy and other vision problems. The drug can cause a variety of symptoms associated with maculopathy, including:

• Adult pattern macular dystrophy
• Hyperpigmentation or dark spots on the retina
• Abnormal blood vessels and capillaries around the macula
• Retinal pigment epithelium atrophy

Other complications associated with the use of Elmiron® include:

• Blurred vision
• Dark spots
• Difficulty reading
• Difficulty focusing on items in the field of vision
• Blindness
• Halo vision